Tirzepatide vs Semaglutide vs Retatrutide Three incretin-class compounds dominate the conversation: tirzepatide (dual GIP/GLP-1), semaglutide (GLP-1 only, sold as Ozempic and Wegovy), and retatrutide (triple agonist GLP-1 + GIP + glucagon, still investigational)
The results of this study also showed that, there was a positive correlation between the externalization of PS and the generation of ROS (r = 0.65)
As research on DSIP use in humans is continually expanding, researchers are advised to stay informed on the latest developments and recommendations regarding this peptide
Some GLP-1 medicines are injections, while others are tablets
Clinicians should monitor thyroid function tests (TSH, free T4) at: Baseline before starting weight loss injections 6-8 weeks after achieving maintenance dose Every 3-6 months during active weight loss After significant weight stabilization Symptoms of overreplacement (palpitations, anxiety, tremor, heat intolerance) should prompt earlier testing
She is a practicing endocrinologist who specializes in treating patients with obesity